These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10022531)

  • 41. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice.
    Gallo-Penn AM; Shirley PS; Andrews JL; Kayda DB; Pinkstaff AM; Kaloss M; Tinlin S; Cameron C; Notley C; Hough C; Lillicrap D; Kaleko M; Connelly S
    Hum Gene Ther; 1999 Jul; 10(11):1791-802. PubMed ID: 10446919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors.
    Miao CH; Ye X; Thompson AR
    Hum Gene Ther; 2003 Sep; 14(14):1297-305. PubMed ID: 14503965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toward gene therapy in haemophilia A: retrovirus-mediated transfer of a factor VIII gene into murine haematopoietic progenitor cells.
    Hoeben RC; Einerhand MP; Briët E; van Ormondt H; Valerio D; van der Eb AJ
    Thromb Haemost; 1992 Mar; 67(3):341-5. PubMed ID: 1641825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correction of murine hemophilia A following nonmyeloablative transplantation of hematopoietic stem cells engineered to encode an enhanced human factor VIII variant using a safety-augmented retroviral vector.
    Ramezani A; Hawley RG
    Blood; 2009 Jul; 114(3):526-34. PubMed ID: 19470695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic induction of a releasable pool of factor VIII in human endothelial cells.
    Rosenberg JB; Greengard JS; Montgomery RR
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2689-95. PubMed ID: 11116073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
    Van Damme A; Chuah MK; Collen D; VandenDriessche T
    Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced plasma factor VIII activity in mice via cysteine mutation using dual vectors.
    Zhu F; Liu Z; Miao J; Qu H; Chi X
    Sci China Life Sci; 2012 Jun; 55(6):521-6. PubMed ID: 22744182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ibalpha promoter: in vivo model for platelet-targeting gene therapy.
    Ohmori T; Mimuro J; Takano K; Madoiwa S; Kashiwakura Y; Ishiwata A; Niimura M; Mitomo K; Tabata T; Hasegawa M; Ozawa K; Sakata Y
    FASEB J; 2006 Jul; 20(9):1522-4. PubMed ID: 16723382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correction of bleeding diathesis without liver toxicity using arenaviral-pseudotyped HIV-1-based vectors in hemophilia A mice.
    Park F
    Hum Gene Ther; 2003 Oct; 14(15):1489-94. PubMed ID: 14577928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector.
    Scallan CD; Lillicrap D; Jiang H; Qian X; Patarroyo-White SL; Parker AE; Liu T; Vargas J; Nagy D; Powell SK; Wright JF; Turner PV; Tinlin SJ; Webster SE; McClelland A; Couto LB
    Blood; 2003 Sep; 102(6):2031-7. PubMed ID: 12738670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Retroviral-mediated high efficient in vitro expression of human coagulation factor VIII].
    Guo X; Wang H; Chu H; Wang X; Qu B; Li Z; Qi Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):457-9. PubMed ID: 11877017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene.
    Ishiwata A; Mimuro J; Kashiwakura Y; Niimura M; Takano K; Ohmori T; Madoiwa S; Mizukami H; Okada T; Naka H; Yoshioka A; Ozawa K; Sakata Y
    Thromb Res; 2006; 118(5):627-35. PubMed ID: 16371232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene therapy strategies for hemophilia: benefits versus risks.
    Petrus I; Chuah M; VandenDriessche T
    J Gene Med; 2010 Oct; 12(10):797-809. PubMed ID: 20848668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcutaneous ultrasound-mediated gene delivery into canine livers achieves therapeutic levels of factor VIII expression.
    Manson MA; Zhang F; Novokhodko A; Chen CY; Parker M; Loeb KR; Kajimoto M; Campbell C; Storb RF; Miao CH
    Blood Adv; 2022 Jun; 6(12):3557-3568. PubMed ID: 35427415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
    Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-viral ex vivo transduction of human hepatocyte cells to express factor VIII using a human ribosomal DNA-targeting vector.
    Liu X; Liu M; Xue Z; Pan Q; Wu L; Long Z; Xia K; Liang D; Xia J
    J Thromb Haemost; 2007 Feb; 5(2):347-51. PubMed ID: 17155951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apoptotic effects of platelet factor VIII on megakaryopoiesis: implications for a modified human FVIII for platelet-based gene therapy.
    Greene TK; Lyde RB; Bailey SC; Lambert MP; Zhai L; Sabatino DE; Camire RM; Arruda VR; Poncz M
    J Thromb Haemost; 2014 Dec; 12(12):2102-12. PubMed ID: 25287191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modified expi293 cell culture system using piggyBac transposon enables efficient production of human FVIII.
    Yoshimura T; Horiuchi K; Shimonishi N; Ogiwara K; Horie K; Shima M; Nogami K
    Int J Hematol; 2023 Jan; 117(1):56-67. PubMed ID: 36229740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Animal testing of retroviral-mediated gene therapy for factor VIII deficiency.
    Greengard JS; Jolly DJ
    Thromb Haemost; 1999 Aug; 82(2):555-61. PubMed ID: 10605751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.